Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02248935 · ClinicalTrials.gov registry record

Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy

A clinical trial of Pelvic Organ Prolapse, sponsored by Atlantic Health System.

Completed
Registry status
316
Enrollment target
1
Study location

NCT02248935 is a study of Pelvic Organ Prolapse that has completed, run by Atlantic Health System. The registered enrollment target is 316 participants, above the 137-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (131% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02248935, a study of Pelvic Organ Prolapse, has completed, sponsored by Atlantic Health System.

COMPLETED
Registry status
316 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the clinical cure rates of pelvic organ prolapse from subjects that had a robotic-assisted sacrocolpopexy using Alyte Y mesh and Restorelle Y smartmesh lightweight mesh.

Conditions Studied

Study Locations (1)

New Jersey

  • Department of Urogynecology-Atlantic Health System - Morristown

Trial Details

FieldValue
Enrollment Target 316 participants
Start Date 2014-07
Est. Completion 2015-08

Sponsor

Atlantic Health System

43 total trials

What the Registry Record Tells You About NCT02248935

The ClinicalTrials.gov registry entry for NCT02248935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 137-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (131% higher). The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.

NCT02248935 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02248935 about?

NCT02248935 is a clinical study titled "Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy". The purpose of the study is to determine the clinical cure rates of pelvic organ prolapse from subjects that had a robotic-assisted sacrocolpopexy using Alyte Y mesh and Restorelle Y smartmesh lightweight mesh.

What is the current status of trial NCT02248935?

This trial is currently completed. The enrollment target is 316 participants. The study started on 2014-07. Estimated completion is 2015-08.

What conditions does trial NCT02248935 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

Who is sponsoring clinical trial NCT02248935?

This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02248935 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.